GlaxoSmithKline PLCAdd to My Watchlist

GSK:USNew YorkIndustry: Medical-Drugs
  • 45.01
  • 0.05  0.11%
    Today's Change
  • 44.96
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 1/23/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding2 billion
Market Cap$109 billion
Return on Equity ttm75.96%
Last Dividend$0.61
Dividend Yield ttm5.89
Relative Dividend Yield benchmark3.00
Dividend Ex-Date11/5/14
Dividend Pay Date1/8/15
EPS: Year Actual ttm--
EPS: Year Est. 12/14 ttm1.870
EPS: Quarterly Actual 9/14 --
EPS: Quarterly Est. 12/14 0.53
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate22.82
Company Description
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
Revenue$27 billion
Net Income$5 billion
Total Assets$42 billion

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!